Rothschild Capital Partners’s Boston Scientific BSX Stock Holding History

Rothschild Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,066	Closed	-$483K	–	95
2025 Q4	$483K	Hold	5,066	–	–	0.11%	49
2025 Q3	$495K	Hold	5,066	–	–	0.12%	51
2025 Q2	$544K	Hold	5,066	–	–	0.14%	40
2025 Q1	$511K	Buy	5,066 +940	+23%	+$94.7K	0.13%	46
2024 Q4	$369K	Buy	+4,126	New	+$363K	0.09%	61
2016 Q4	–	Sell	-124,865	Closed	-$2.97M	–	57
2016 Q3	$2.97M	Buy	+124,865	New	+$2.98M	1.07%	36

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rothschild Capital Partners's BSX Position: Q1 2026 in Review

Rothschild Capital Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 5,066 shares — an estimated $483K sold.

Rothschild Capital Partners first reported a position in BSX in Q3 2016 and held it in 6 quarters. The position peaked at $2.97M in Q3 2016. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Rothschild Capital Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Rothschild Capital Partners sold 5,066 Boston Scientific shares in Q1 2026, an estimated $483K.
Rothschild Capital Partners first reported a position in Boston Scientific in Q3 2016 and held it in 6 quarters.
Rothschild Capital Partners's Boston Scientific position peaked at $2.97M in Q3 2016.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Rothschild Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.